Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.
Saved in:
| Title: | Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer. |
|---|---|
| Authors: | Zhang X; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Zeng J; School of Life Science and Technology, Computational Biology Research Center, Harbin Institute of Technology, Harbin 150001, China., Wang J; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Yang Z; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Gao S; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Liu H; School of Life Science and Technology, Computational Biology Research Center, Harbin Institute of Technology, Harbin 150001, China., Li G; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Zhang X; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China., Gu Y; School of Life Science and Technology, Computational Biology Research Center, Harbin Institute of Technology, Harbin 150001, China., Pang D; Department of Breast Surgery, Harbin Medical University Cancer Hospital,150 Haping Road, Harbin 150081, China. |
| Source: | Genes [Genes (Basel)] 2022 Dec 18; Vol. 13 (12). Date of Electronic Publication: 2022 Dec 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101551097 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4425 (Electronic) Linking ISSN: 20734425 NLM ISO Abbreviation: Genes (Basel) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
